JP MORGAN/CALL/ABBOTT LABORATORIES/105/0.1/21.06.24 Stock

Warrant

DE000JS6TPB1

Market Closed - Börse Stuttgart 04:28:58 2024-06-14 am EDT
0.049 EUR -55.45% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/105/0.1/21.06.24
Current month-30.00%
1 month-78.70%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 0.049 -55.45%
24-06-13 0.11 -35.29%
24-06-12 0.17 -46.88%
24-06-11 0.32 -13.51%
24-06-10 0.37 +164.29%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 04:28 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JS6TPB
ISINDE000JS6TPB1
Date issued 2023-02-16
Strike 105 $
Maturity 2024-06-21 (5 Days)
Parity 10 : 1
Emission price 1.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.65
Lowest since issue 0.049
Spread 0.01
Spread %13.51%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus